Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Solutions

Increase effective public funding

Increase effective public funding

Increase effective public funding

Populations most in need of new technologies to combat endemic and emerging global health challenges are often least able to pay for treatment and health services. Consequently, diseases and conditions impacting these populations are often neglected by private-sector product developers, because there is little to no prospect for return on their investment in R&D. Therefore, public funding for global health R&D plays a critical role in advancing the development of tools and technologies that, while urgently needed by populations around the world, lack a robust commercial market to incentivize their development.

The United States leads the world in public investment in global health R&D through programs at the US Agency for International Development, Centers for Disease Control and Prevention, National Institutes of Health, Biomedical Advanced Research and Development Authority, Food and Drug Administration, and Department of Defense. With relatively modest investments in global health R&D, the United States has contributed to breakthroughs including the first blood test for HIV/AIDS, a single-dose cure for relapsing malaria, and the world's first vaccine for Ebola.

While the United States plays a critical role in investment in global health R&D, global health challenges require a global response. Other top public funders include the United Kingdom, the European Commission, Switzerland, Netherlands, South Africa, and Germany. Sustaining funding from traditional donors, as well as incentivizing greater investment from emerging economies, is critical to accelerating momentum in global health.

R&D investments today are a down payment on the innovations of tomorrow. Global health R&D takes significant time and resources, and sustained and reliable government investment is essential for researchers to have the resources they need to develop the tools and technologies we need to meet our global health goals.

What does GHTC do?

GHTC advocates for sufficient and effective public funding for global health R&D. In the United States, the coalition works with Congress, the Administration, and the six US agencies involved in global health R&D to highlight the vital role the United States plays in global health innovation, create policies that promote global health R&D, and develop champions who will continue to prioritize US investment.

At the global level, GHTC works through coalitions and with partner groups to champion international investments in global health R&D from individual governments, as well as regional and multilateral organizations.

Back to Solutions
Increase effective public funding

Increase effective public funding

Learn More
Enhance efficiency and effective use of resources

Enhance efficiency and effective use of resources

Learn More
Advance multisector partnerships

Advance multisector partnerships

Learn More
Strengthen regulatory pathways

Strengthen regulatory pathways

Learn More
Incentivize greater private sector investment and engagement

Incentivize greater private sector investment and engagement

Learn More
Promote innovative financing mechanisms

Promote innovative financing mechanisms

Learn More
Learn more about GHTC's recent advocacy actions.
Taking Action

Learn more about GHTC's recent advocacy actions.

Learn More
Explore GHTC's Resources

Explore GHTC's Resources

Global Health Technologies Coalition
Stay Informed

Sign up to receive news and updates from GHTC.

Sign Up Now
Our Members work to improve health worldwide
ACTION
American Society of Tropical Medicine and Hygiene
AVAC
BD
Bill & Melinda Gates Foundation
Coalition for Health Research and Development (CHReaD)
Deutsche Stiftung Weltbevölkerung
Drugs for Neglected Diseases initiative
Elizabeth Glaser Pediatric AIDS Foundation
FIND
Global Health Council
Global Health Innovative Technology Fund
Global Health Investment Fund
HarvestPlus
IAVI
Infectious Disease Society of America
International Partnership for Microbicides
International Vaccine Institute
IVCC
Jhpiego
Johnson & Johnson
Medicines for Malaria Venture
PATH
Policy Cures Research
RESULTS
Sabin Vaccine Institute
South Africa Health Technologies Advocacy Coalition (SAHTAC)
TB Alliance
Treatment Action Group
Washington Global Health Alliance
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In